MX303646A - Sistema portador contra la hormona de liberacion de gonadotropina. - Google Patents

Sistema portador contra la hormona de liberacion de gonadotropina.

Info

Publication number
MX303646A
MX303646A MX303646A MX9303646A MX303646A MX 303646 A MX303646 A MX 303646A MX 303646 A MX303646 A MX 303646A MX 9303646 A MX9303646 A MX 9303646A MX 303646 A MX303646 A MX 303646A
Authority
MX
Mexico
Prior art keywords
carrier system
gnrh
system against
release hormone
against gnrh
Prior art date
Application number
MX303646A
Other languages
English (en)
Spanish (es)
Inventor
Josephus Theodorus Gielen
Anna Van Der Zee
Irma Marianne Van Die
Willem Pieter Martin Hoekstra
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of MX303646A publication Critical patent/MX303646A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Gyroscopes (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX303646A 1992-06-18 1993-06-17 Sistema portador contra la hormona de liberacion de gonadotropina. MX303646A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92201775 1992-06-18

Publications (1)

Publication Number Publication Date
MX303646A true MX303646A (es) 1994-05-31

Family

ID=8210697

Family Applications (1)

Application Number Title Priority Date Filing Date
MX303646A MX303646A (es) 1992-06-18 1993-06-17 Sistema portador contra la hormona de liberacion de gonadotropina.

Country Status (18)

Country Link
US (2) US5684145A (enExample)
EP (1) EP0578293B1 (enExample)
JP (1) JPH0656696A (enExample)
KR (1) KR100293025B1 (enExample)
AT (1) ATE188737T1 (enExample)
AU (1) AU667715B2 (enExample)
BR (1) BR9302408A (enExample)
CA (1) CA2098533C (enExample)
DE (1) DE69327553T2 (enExample)
DK (1) DK0578293T3 (enExample)
ES (1) ES2142848T3 (enExample)
GR (1) GR3033086T3 (enExample)
HU (1) HU217096B (enExample)
MX (1) MX303646A (enExample)
NZ (1) NZ247907A (enExample)
PT (1) PT578293E (enExample)
TW (1) TW240232B (enExample)
ZA (1) ZA934199B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
EP0596959B1 (en) * 1991-07-26 2000-03-29 Commonwealth Scientific And Industrial Research Organisation Self-adjuvanting peptide vaccine delivery system and production thereof
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
AU1532795A (en) * 1994-01-27 1995-08-15 Gx Biosystems A/S Receptor specific bacterial adhesins and their use
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6635740B1 (en) * 1997-03-27 2003-10-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Ligand/lytic peptide compositions and methods of use
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6013770A (en) * 1997-07-21 2000-01-11 Washington State University Chimeric contraceptive vaccines
US6258782B1 (en) 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
AUPP807399A0 (en) 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
DE60017211T2 (de) * 1999-02-17 2005-06-02 Pfizer Products Inc., Groton Fusionsproteine mit Trägern welche eine doppelte Immunantwort induzieren
WO2001085763A2 (en) * 2000-05-05 2001-11-15 Aphton Corporation Chimeric peptide immunogens their preparation and use
EP1278542A2 (en) 2000-05-05 2003-01-29 Cytos Biotechnology AG Molecular antigen arrays and vaccines
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
JP4671389B2 (ja) * 2001-10-05 2011-04-13 サイトス バイオテクノロジー アーゲー アンジオテンシンペプチド−担体複合体およびその使用
JP4644488B2 (ja) 2002-07-19 2011-03-02 サイトス・バイオテクノロジー・アクチェンゲゼルシャフト アミロイドベータ1−6抗原アレイを含むワクチン組成物
US7537767B2 (en) 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
AU2004224762B2 (en) 2003-03-26 2009-12-24 Kuros Us Llc Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
EP0264150B1 (fr) * 1986-10-13 1993-01-07 Solvay Microorganismes comportant des pili comme protéines porteuses, pili isolés à partir de ces microorganismes, procédé d'excrétion de peptides ou de protéines à l'aide de ces pili et utilisation de ceux-ci
AU616662B2 (en) * 1987-04-27 1991-11-07 Commonwealth Scientific And Industrial Research Organisation Peptide production by protein engineering
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
US5036047A (en) * 1988-09-29 1991-07-30 Pitman-Moore, Inc. Method and composition for preventing conception
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Also Published As

Publication number Publication date
EP0578293B1 (en) 2000-01-12
EP0578293A1 (en) 1994-01-12
HU217096B (hu) 1999-11-29
US6019983A (en) 2000-02-01
JPH0656696A (ja) 1994-03-01
KR100293025B1 (ko) 2001-09-17
ZA934199B (en) 1994-01-10
PT578293E (pt) 2000-06-30
GR3033086T3 (en) 2000-08-31
NZ247907A (en) 1994-12-22
AU667715B2 (en) 1996-04-04
ES2142848T3 (es) 2000-05-01
ATE188737T1 (de) 2000-01-15
HUT68554A (en) 1995-06-28
CA2098533A1 (en) 1993-12-19
US5684145A (en) 1997-11-04
HU9301764D0 (en) 1993-10-28
BR9302408A (pt) 1994-01-11
TW240232B (enExample) 1995-02-11
DE69327553T2 (de) 2000-08-10
DK0578293T3 (da) 2000-06-26
DE69327553D1 (de) 2000-02-17
KR940000115A (ko) 1994-01-03
AU4134393A (en) 1993-12-23
CA2098533C (en) 2005-08-16

Similar Documents

Publication Publication Date Title
MX303646A (es) Sistema portador contra la hormona de liberacion de gonadotropina.
ES2073028T3 (es) Anticuerpos y peptidos inmunoactivos y su utilizacion en tratamiento anti-alergico.
DE69632235D1 (de) Newcastle-Krankheitsvirus-Kombinationsimpfstoff
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
PT815235E (pt) Vacinas para peste
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
BR9811184A (pt) Vetor de adenovìrus porcino recombinante emétodo de produzir o mesmo
ES2123558T3 (es) Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc.
KR930703443A (ko) 정자 세포 표면 단백질 ph-20 및 그것의 피임 백신에서의 용도
Franke et al. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides
EA200200142A1 (ru) Способ выделения вариантов ротавирусов и живая ослабленная ротавирусная вакцина
ES2100240T3 (es) Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
ATE262539T1 (de) Immunoreaktive peptid ctl epitope von menschlichem cytomegalovirus
CA2057828A1 (en) Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
DK0832107T3 (da) Forbedret peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af dyr mod hormonet LHRH samt analoge af LHRH-tandempeptid-gentagelsespeptidet og deres andvendelse som vaccine
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
ES2143996T3 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
ES2177648T3 (es) Vacuna sintetica para proteccion frente a infeccion por virus de inmunodeficiencia humana.
AR248046A1 (es) Biosintesis de una secuencia de adn codificante de una glicoproteina inmunogena de hospedantes de garrapatas, sonda de hibridizacion, moleculas de dna, transformantes y plasmidos.
FI932759A0 (fi) Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner
KR890008171A (ko) 펩타이드 구조물, 이를 함유하는 면역원 및 수정율 억제에 있어서 이의 용도
RU2003110420A (ru) Дифференцирование gnrh-i и gnrh-ii
ES2058240T3 (es) Nuevos peptidos sinteticos inmunologicamente activos utiles para la preparacion de una vacuna antimalarica.
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
IT1226728B (it) Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees